EUVIMEDEUVIMED entdecken
Crossref

Berberine attenuates liver fibrosis via inhibition of Ang-2 through the toll-like receptor 4-mediated signaling pathway

Hong Wang, Yanan Zhou, Wenlu He, Fulan Zhao, Roman Spáčil, Wei Ren, Yining Ma

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115673 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Hong Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Traditional Chinese Medicine Clinical Research Base and Drug Research Center, the Affiliated Traditional Chinese Medicine Hospital, Southwes…. Hauptthemen laut MEDLINE: Berberine, Toll-Like Receptor 4, Angiopoietin-2, Liver Cirrhosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Health Commission of Sichuan Province, Sichuan Provincial Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis, a key pathological feature in chronic liver injury, accelerates chronic liver disease (CLD) progression to cirrhosis. Fibrogenesis relies on angiogenesis balance, namely, physiological angiogenesis mitigates liver injury while pathological angiogenesis drives excessive collagen deposition and fibrotic progression. Therefore, targeting key regulators governing the transition from physiological to pathological angiogenesis is critical for treating liver fibrosis. In this study, two murine models of chronic liver injury were established: a carbon tetrachloride (CCl4)-induced fibrosis model and a non-alcoholic steatohepatitis (NASH) model. Both models exhibited elevated angiopoietin-2 (Ang-2) levels, concomitant with marked activation of endothelial-mesenchymal transition (EMT). Furthermore, to delineate the angiogenic role of Ang-2, liver-specific Ang-2 knockdown (Ang-2-/-) mice were generated. Ang-2 gene deletion attenuated EMT activation, demonstrating its critical contribution to fibrogenesis. Finally, berberine (BBR), a hepatoprotective alkaloid derived from Rhizoma Coptidis, attenuated liver fibrosis by suppressing Ang-2 expression through TLR4 signaling inhibition. In summary, this study highlights the therapeutic potential of BBR for its clinical application by identifing Ang-2 as a novel regulator of endothelial-cell (EC) proliferation in liver fibrosis and demonstrates that BBR inhibits fibrogenesis via TLR4-mediated Ang-2 suppression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineToll-Like Receptor 4Angiopoietin-2Liver CirrhosisNon-alcoholic Fatty Liver DiseaseAnimalsSignal TransductionMiceCarbon TetrachlorideMice, Inbred C57BLMaleHumansMice, KnockoutLiverDisease Models, AnimalEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

Angiopoietin-2BerberineLiver fibrosisToll-like receptor 4 signaling pathway

Substanzen

BerberineToll-Like Receptor 4Angiopoietin-2Carbon TetrachlorideTlr4 protein, mouse

Autor:innen und Institutionen

  • National Traditional Chinese Medicine Clinical Research Base and Drug Research Center, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China; Institute of Integrated Ch…
  • Sino-Portugal TCM International Cooperation Center, the Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China.
  • The Czech Center for Traditional Chinese Medicine, Jeremenkova 1211/40, Olomouc 77900, Czechia. Electronic address: roman@czcn.eu.

Förderung

  • Health Commission of Sichuan Province
  • Sichuan Provincial Science and Technology Support Program

Zitieren

APA

Wang, H., Zhou, Y., He, W., Zhao, F., Spáčil, R., Ren, W., & Ma, Y. (2025). Berberine attenuates liver fibrosis via inhibition of Ang-2 through the toll-like receptor 4-mediated signaling pathway. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115673

Vancouver

Wang H, Zhou Y, He W, Zhao F, Spáčil R, Ren W, et al. Berberine attenuates liver fibrosis via inhibition of Ang-2 through the toll-like receptor 4-mediated signaling pathway. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115673

BibTeX
@article{Wang2025,
  author = {Wang, Hong and Zhou, Yanan and He, Wenlu and Zhao, Fulan and Spáčil, Roman and Ren, Wei and Ma, Yining},
  title = {Berberine attenuates liver fibrosis via inhibition of Ang-2 through the toll-like receptor 4-mediated signaling pathway},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115673}
}
Kostenlos starten →